G. Rener

发表

Antineoplastic agents 322. synthesis of combretastatin A-4 prodrugs.

M. Boyd, N. Bansal, N. Bansal, 1995, Anti-cancer drug design.

Metabolism of LY654322, a Growth Hormone Secretagogue, to an Unusual Diimidazopyridine Metabolite

P. Kulanthaivel, W. J. Wheeler, V. Klimkowski, 2011, Drug Metabolism and Disposition.

Tubulin binding properties of two chiral isomers with 1-deaza-7,8-dihydropteridine structure.

V. Peyrot, C. Briand, J. Andreu, 1993, Advances in experimental medicine and biology.

Synthesis of potential anticancer agents: imidazo[4,5-c]pyridines and imidazo[4,5-b]pyridines.

J. Rose, C. Temple, G. Rener, 1987, Journal of medicinal chemistry.

Antimitotic agents: structure-activity studies with some pyridine derivatives.

W. Waud, P. Noker, C. Temple, 1992, Journal of medicinal chemistry.

Selective reduction of N-oxides to amines: application to drug metabolism.

Lawrence A. Goodwin, P. Kulanthaivel, P. Yi, 2004, Drug metabolism and disposition: the biological fate of chemicals.

Phosphonate analogs of carbocyclic nucleotides.

J. Montgomery, W. Parker, J. Secrist, 1994, Journal of medicinal chemistry.

Counterion effects in the preparation of aldehyde–bisulfite adducts

G. Stephenson, R. K. Vaid, C. Alt, 2013 .

High performance liquid chromatographic enantioseparation development and analytical method characterization of the carboxylate ester of evacetrapib using an immobilized chiral stationary phase with a non-conventional eluent system.

C. Wolfe, G. Rener, V. S. Sharp, 2015, Journal of chromatography. A.

Rapid Development and Scale-Up of a 1H-4-Substituted Imidazole Intermediate Enabled by Chemistry in Continuous Plug Flow Reactors

Martin D. Johnson, Scott A. May, Timothy M. Braden, 2012 .

Tubulin binding of two 1-deaza-7,8-dihydropteridines with different biological properties: enantiomers NSC 613862 (S)-(-) and NSC 613863 (R)-(+).

V. Peyrot, C. Briand, C Briand, 1993, Biochemistry.

Antimitotic agents: ring analogues and derivatives of ethyl [(S)-5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7- yl]carbamate.

C. Temple, G. Rener, 1992, Journal of medicinal chemistry.

Action of a deazapteridine on microtubular system effect of chirality

I. Barasoain, V. Peyrot, C. Briand, 1992 .

Antimitotic agents. Chiral isomers of ethyl [5-amino-1,2-dihydro-3-(4-hydroxyphenyl)-2-methylpyrido[3,4-b]pyrazin-7 -yl]carbamate.

C. Temple, G. Rener, 1992, Journal of medicinal chemistry.

New Anticancer Agents: Chiral Isomers of Ethyl 5-Amino-1,2-dihydro-2-methyl-3-phenylpyrido(3,4-b)pyrazine-7-carbamate.

C. Temple, G. Rener, 1990 .

New anticancer agents: chiral isomers of ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazine-7-car bamate .

C. Temple, G. Rener, 1989, Journal of medicinal chemistry.

Inhibition of microtubules and cell cycle arrest by a new 1-deaza-7,8-dihydropteridine antitumor drug, CI 980, and by its chiral isomer, NSC 613863.

I. Barasoain, V. Peyrot, C. Briand, 1994, Cancer research.